127 related articles for article (PubMed ID: 6177408)
1. Treatment of advanced malignant melanoma with vinblastine, bleomycin, and cisplatin.
Bajetta E; Rovej R; Buzzoni R; Vaglini M; Bonadonna G
Cancer Treat Rep; 1982 Jun; 66(6):1299-302. PubMed ID: 6177408
[TBL] [Abstract][Full Text] [Related]
2. Pilot study of vinblastine and bleomycin combinations in the treatment of metastatic melanoma.
Nathanson L; Wittenberg BK
Cancer Treat Rep; 1980 Jan; 64(1):133-7. PubMed ID: 6155208
[TBL] [Abstract][Full Text] [Related]
3. Cisplatin, vinblastine, and bleomycin in the treatment of metastatic melanoma: a phase II study of the Southeastern Cancer Study Group.
Johnson DH; Presant C; Einhorn L; Bartolucci AA; Greco FA
Cancer Treat Rep; 1985; 69(7-8):821-4. PubMed ID: 2410120
[TBL] [Abstract][Full Text] [Related]
4. Phase II study of the combination of vinblastine, bleomycin, and cisplatin in advanced malignant melanoma.
Creagan ET; Ahmann DL; Schutt AJ; Green SJ
Cancer Treat Rep; 1982 Mar; 66(3):567-9. PubMed ID: 6174231
[No Abstract] [Full Text] [Related]
5. Phase II trial of vinblastine, bleomycin, and cisplatin (VBP) followed by dacarbazine and mitolactol in metastatic melanoma.
Richman SP; Woodcock TM; Kubota TT; Blumenreich MS; Gentile PS; Allegra JC
Cancer Treat Rep; 1984 Nov; 68(11):1395-6. PubMed ID: 6209008
[No Abstract] [Full Text] [Related]
6. Dacarbazine-based chemotherapy for metastatic melanoma: thirty-year experience overview.
Serrone L; Zeuli M; Sega FM; Cognetti F
J Exp Clin Cancer Res; 2000 Mar; 19(1):21-34. PubMed ID: 10840932
[TBL] [Abstract][Full Text] [Related]
7. Final report of a phase II study of chemotherapy with bleomycin, epirubicin, and cisplatin for locally advanced and metastatic/recurrent undifferentiated carcinoma of the nasopharyngeal type.
Azli N; Fandi A; Bachouchi M; Rahal M; Lianes P; Wibault P; Boussen H; Eschwege F; Armand JP; Cvitkovic E
Cancer J Sci Am; 1995; 1(3):222-9. PubMed ID: 9166480
[TBL] [Abstract][Full Text] [Related]
8. Lomustine (chloroethylnitrosourea [CCNU]), ifosfamide, bleomycin, vincristine, and cisplatin (CIBO-P) is an effective regimen for patients with poor prognostic refractory or multiple disease recurrent aggressive non-Hodgkin lymphoma.
Musolino A; Perrone MA; Michiara M; Delnevo D; Franciosi V; Di Blasio B; Ceci G; Camisa R; Ardizzoni A; Cocconi G
Cancer; 2005 May; 103(10):2109-17. PubMed ID: 15803492
[TBL] [Abstract][Full Text] [Related]
9. Sequential combination chemotherapy with vinblastine-bleomycin and doxorubicin-cis-dichlorodiammineplatinum(II) in disseminated nonseminomatous testicular cancer.
Scheulen ME; Seeber S; Schilcher RB; Meier CR; Schmidt CG
Cancer Treat Rep; 1980; 64(4-5):599-609. PubMed ID: 6159077
[TBL] [Abstract][Full Text] [Related]
10. [Treatment of refractory malignant lymphomas with cisplatin, vinblastine, and bleomycin].
Avilés A; Díaz-Maqueo JC; Torras V
Rev Invest Clin; 1990; 42(2):99-102. PubMed ID: 1702554
[TBL] [Abstract][Full Text] [Related]
11. Bleomycin, vinorelbine and trofosfamide in relapsed stage IV cutaneous malignant melanoma patients.
Atzpodien J; Morawek L; Fluck M; Reitz M
Cancer Chemother Pharmacol; 2009 Oct; 64(5):901-5. PubMed ID: 19229537
[TBL] [Abstract][Full Text] [Related]
12. Cisplatin, vinblastine and bleocin in the treatment of disseminated testicular cancer.
Koynov KD; Tzekova VI; Velikova MT
Int Urol Nephrol; 1993; 25(4):389-94. PubMed ID: 7506242
[TBL] [Abstract][Full Text] [Related]
13. Lomustine, bleomycin, and cisplatin in patients with metastatic malignant melanoma.
Cohen SM; Ohnuma T; Ambinder EP; Holland JF
Cancer Treat Rep; 1986 May; 70(5):688-9. PubMed ID: 2423239
[No Abstract] [Full Text] [Related]
14. Combination chemotherapy for metastatic or locally advanced genitourinary squamous cell carcinoma: a phase II study of methotrexate, cisplatin and bleomycin.
Corral DA; Sella A; Pettaway CA; Amato RJ; Jones DM; Ellerhorst J
J Urol; 1998 Nov; 160(5):1770-4. PubMed ID: 9783949
[TBL] [Abstract][Full Text] [Related]
15. Phase II study of the combination of vinblastine plus cisplatin administered by continuous 120-hour infusion for patients with advanced malignant melanoma.
Creagan ET; Ahmann DL; Schutt AJ; Schaid DJ
Cancer Treat Rep; 1987; 71(7-8):769-70. PubMed ID: 3607788
[No Abstract] [Full Text] [Related]
16. Treatment of recurrent and persistent germ cell tumors with cisplatin, vinblastine, and bleomycin.
Jacobs AJ; Harris M; Deppe G; DasGupta I; Cohen CJ
Obstet Gynecol; 1982 Jan; 59(1):129-32. PubMed ID: 6176923
[TBL] [Abstract][Full Text] [Related]
17. [Combination of dacarbazine, cisplatin and interferon alpha in the treatment of metastatic melanoma].
Tessier MH; Mansat E; Legoux B; Litoux P; Dreno B
Ann Dermatol Venereol; 1996; 123(9):538-42. PubMed ID: 9615103
[TBL] [Abstract][Full Text] [Related]
18. Systemic therapy for unresectable metastatic melanoma: impact of biochemotherapy on long-term survival.
Bedikian AY; Johnson MM; Warneke CL; McIntyre S; Papadopoulos N; Hwu WJ; Kim K; Hwu P
J Immunotoxicol; 2008 Apr; 5(2):201-7. PubMed ID: 18569391
[TBL] [Abstract][Full Text] [Related]
19. Treatment of poor-prognosis sex cord-stromal tumors of the ovary with the combination of bleomycin, etoposide, and cisplatin.
Gershenson DM; Morris M; Burke TW; Levenback C; Matthews CM; Wharton JT
Obstet Gynecol; 1996 Apr; 87(4):527-31. PubMed ID: 8602303
[TBL] [Abstract][Full Text] [Related]
20. [Current results with surgery and adjuvant chemotherapy in malignant melanoma].
Mechl Z; Kopecný J
Arch Geschwulstforsch; 1986; 56(5):367-71. PubMed ID: 2429631
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
